Vanderbilt Institute of Imaging Science Archives
Dec. 12, 2019—John Gore, PhD, has been appointed to a National Academies of Sciences, Engineering and Medicine standing committee to advise the Department of State on unexplained health effects on U.S. government employees and their families at overseas embassies.
Nov. 7, 2019—GE Healthcare has awarded researchers in the Vanderbilt University Institute of Imaging Science $2.5 million in funding to develop PET tracer that will determine the effectiveness of immunotherapy in patients early in their treatment course.
Nov. 7, 2019—Vanderbilt researchers are developing a focused ultrasound neuromodulation device as a non-invasive and non-addictive method for treating chronic pain.
Jun. 13, 2019—Todd Peterson, PhD, associate professor of Radiology and Radiological Sciences, has been appointed director of the Vanderbilt University Institute of Imaging Science (VUIIS) Radiochemistry Core Lab, following the departure of Michael Nickels, PhD.
May. 22, 2019—John Gore, PhD, and Michael King, PhD, were recently elected to the International Academy of Medical and Biological Engineering (IAMBE) 2019 Class of Fellows in recognition of their contributions in the field of medical and biological engineering.
Jun. 7, 2018—A research-dedicated PET/CT scanner installed recently in the Vanderbilt University Institute of Imaging Science (VUIIS) will expand opportunities for Vanderbilt researchers to conduct studies of a wide range of disorders, from cancer to Alzheimer’s disease.
Apr. 19, 2018—A Vanderbilt University Medical Center-led research team has shown that magnetic resonance imaging (MRI) can detect changes in resting-state spinal cord function in patients with multiple sclerosis (MS).
Study finds common brain scanning technique maps electrical activity as precisely as more invasive methods
May. 25, 2017—A commonly used brain scanning technique can map electrical activity under the skull as precisely as more invasive methods that rely on probes or electrodes, researchers at Vanderbilt University Medical Center (VUMC) reported this month.
Sep. 22, 2016—Vanderbilt University Medical Center is the world’s first site to treat a patient in the TULSA-PRO Ablation Clinical Trial (TACT), which employs an emerging therapy that uses MRI guidance and robotically driven therapeutic ultrasound to obtain precise prostate cancer tissue ablation.